✦ LIBER ✦

Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus

✍ Scribed by C. Pan; X. Xing; P. Han; S. Zheng; J. Ma; J. Liu; X. Lv; J. Lu; G. Bader; on behalf of all investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of vildaglipti

✍ Masatoshi Kikuchi; Masakazu Haneda; Daisuke Koya; Kazuyuki Tobe; Yukiko Onishi; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Efficacy and tolerability of vildaglipti

✍ F. Xavier Pi-Sunyer; Anja Schweizer; David Mills; Sylvie Dejager 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 236 KB

The efficacy and tolerability of add-on

✍ I. Kinalska; V. Novikov; G. Tamas; S. Czekalski; M. Balabolkin; Z. Szybinski; J. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Long-term efficacy and tolerability of a

✍ B. Charbonnel; G. Schernthaner; P. Brunetti; D. R. Matthews; R. Urquhart; M. H. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 244 KB

Assessment of efficacy and tolerability

✍ Juliana Levy; Roberta A Cobas; Marília B Gomes 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 331 KB

Efficacy and tolerability of vildaglipti

✍ W. A. Scherbaum; A. Schweizer; A. Mari; P. M. Nilsson; G. Lalanne; S. Jauffret; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB